Skip to content
Screener

Exelixis EXEL Income Tax

Income Tax at other companies

Eli Lilly logo
Eli LillyLLY
$2.15B+92.8%
Pfizer logo
PfizerPFE
-$407M-389%
Kura Oncology logo
Kura OncologyKURA
$8K-96.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0
Opko Health logo
Opko HealthOPK
-$4.98M+64.6%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$6.1M+134%

Segments

By segment

See full
Reportable Segment$50.63M+11.1%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income14,21016,78930,33735,865
Other income (expenses), net5450273(195)
Income before income taxes262,678230,415530,365436,105
Provision for income taxes50,62845,567107,84891,641
Net income$212,050$184,848$422,517$344,464
Net income per share:
Basic$0.85$0.68$1.66$1.25
Diluted$0.82$0.65$1.60$1.20

Item 1. Financial Statements.

FAQ

What is Exelixis's income tax?
Exelixis (EXEL) reported income tax of $50.63M in Q2 2026.
How has Exelixis's income tax changed year-over-year?
Exelixis's income tax increased by 11.1% year-over-year, from $45.57M to $50.63M.
What is the long-term trend for Exelixis's income tax?
Over 4 years (2021 to 2025), Exelixis's income tax has grown at a 25.9% compound annual growth rate (CAGR), from $63.09M to $158.64M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about Exelixis's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude